Does METHYLPREDNISOLONE Cause Interstitial lung disease? 579 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 579 reports of Interstitial lung disease have been filed in association with METHYLPREDNISOLONE (Medroloan II SUIK). This represents 0.9% of all adverse event reports for METHYLPREDNISOLONE.
579
Reports of Interstitial lung disease with METHYLPREDNISOLONE
0.9%
of all METHYLPREDNISOLONE reports
227
Deaths
320
Hospitalizations
How Dangerous Is Interstitial lung disease From METHYLPREDNISOLONE?
Of the 579 reports, 227 (39.2%) resulted in death, 320 (55.3%) required hospitalization, and 115 (19.9%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for METHYLPREDNISOLONE. However, 579 reports have been filed with the FAERS database.
What Other Side Effects Does METHYLPREDNISOLONE Cause?
Off label use (10,364)
Drug ineffective (9,959)
Product use in unapproved indication (4,115)
Condition aggravated (3,784)
Headache (3,419)
Fatigue (3,250)
Pyrexia (3,226)
Pain (3,165)
Nausea (3,105)
Pneumonia (3,006)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which METHYLPREDNISOLONE Alternatives Have Lower Interstitial lung disease Risk?
METHYLPREDNISOLONE vs METHYLPREDNISOLONE ACEPONATE
METHYLPREDNISOLONE vs METHYLPREDNISOLONE HEMISUCCINATE
METHYLPREDNISOLONE vs METILDIGOXIN
METHYLPREDNISOLONE vs METOCLOPRAMIDE
METHYLPREDNISOLONE vs METOLAZONE